APA (7th ed.) Citation

Ogasawara, A., Ide, R., Inoue, S., Teng, R., & Kawaguchi, A. (2024). Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dersimelagon (MT‐7117), an Oral Melanocortin‐1 Receptor Agonist. Wiley. https://doi.org/10.1002/cpdd.1413

Chicago Style (17th ed.) Citation

Ogasawara, Akihito, Ryosuke Ide, Shinsuke Inoue, Renli Teng, and Atsuhiro Kawaguchi. Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dersimelagon (MT‐7117), an Oral Melanocortin‐1 Receptor Agonist. Wiley, 2024. https://doi.org/10.1002/cpdd.1413.

MLA (9th ed.) Citation

Ogasawara, Akihito, et al. Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dersimelagon (MT‐7117), an Oral Melanocortin‐1 Receptor Agonist. Wiley, 2024. https://doi.org/10.1002/cpdd.1413.